Unknown

Dataset Information

0

Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.


ABSTRACT: Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are poorly absorbed, short-chain carbohydrates that play an important role in inducing functional gut symptoms. A low-FODMAP diet improves abdominal symptoms in patients with inflammatory bowel disease and irritable bowel syndrome. However, there were no study for the effect of FODMAP content on gastrointestinal intolerance and nutritional status in patients receiving enteral nutrition (EN).In this randomized, multicenter, double-blind, 14-day clinical trial, eligible hospitalized patients receiving EN (n?=?100) were randomly assigned to three groups; 84 patients completed the trial (low-FODMAP EN, n?=?30; moderate-FODMAP EN, n?=?28; high-FODMAP EN, n?=?26). Anthropometric and biochemical parameters were measured; stool assessment was performed using the King's Stool Chart and clinical definition.Baseline values were not significantly different among the three groups. After the 14-day intervention, diarrhea significantly improved in the low-FODMAP group than in the moderate- and high-FODMAP groups (P?

SUBMITTER: Yoon SR 

PROVIDER: S-EPMC4632275 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.

Yoon So Ra SR   Lee Jong Hwa JH   Lee Jae Hyang JH   Na Ga Yoon GY   Lee Kyun-Hee KH   Lee Yoon-Bok YB   Jung Gu-Hun GH   Kim Oh Yoen OY  

Nutrition journal 20151103


<h4>Background</h4>Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are poorly absorbed, short-chain carbohydrates that play an important role in inducing functional gut symptoms. A low-FODMAP diet improves abdominal symptoms in patients with inflammatory bowel disease and irritable bowel syndrome. However, there were no study for the effect of FODMAP content on gastrointestinal intolerance and nutritional status in patients receiving enteral nutrition (EN).<h4  ...[more]

Similar Datasets

| S-EPMC7850813 | biostudies-literature
| S-EPMC7284999 | biostudies-literature
| S-EPMC9733536 | biostudies-literature
| S-EPMC6678336 | biostudies-literature
| S-EPMC9464262 | biostudies-literature
| S-EPMC8952338 | biostudies-literature
| S-EPMC10202059 | biostudies-literature
| S-EPMC9722739 | biostudies-literature
| S-EPMC9701588 | biostudies-literature
| S-EPMC11363362 | biostudies-literature